+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acorda Therapeutics Inc - logo

Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.

Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 236 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Acorda Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Acorda Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Comprehensive Report on Acorda Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Acorda Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2024
  • 43 Pages
From
Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2023
  • 55 Pages
From
Loading Indicator